Mankind Pharma Limited — Important, 14-05-2025: General Updates

Mankind Pharma has announced a board meeting on the financial results for the quarter and half-year. The company faces an additional tax demand of INR 341.86 Cr from the Income Tax Department for past assessment years, linked to adjustments under various tax provisions. Management plans to contest the demand strongly and expects no material financial or operational impact. It is also pursuing a reduction in the demand by claiming prepaid tax credits from merged entities for AY 2022-23.